13F filer · CIK 1832108
ABG-WTT Global Life Science Capital Partners GP Ltd
CENTRAL, HONG KONG, K3 · filing since Q4 2020 · last filing Aug 14, 2026
Reported value
$8.6M
$-3.7M vs prior
Positions
2
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $3.2M
Top-10 weight
100.0%
Biggest buys vs Q1 2026
No new or increased positions this quarter.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | CERIBELL INC | -166,492 | -37.7% | $-3.2M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | CERIBELL INCCOM | 275,328 | $5.4M | 62.61% |
| 2 | RAPID MICRO BIOSYSTEMS INCCLASS A COM | 1,848,296 | $3.2M | 37.39% |